MedPath

The effects of social learning on the efficacy of a treatment with open label placebos in patients with chronic low back pai

Not Applicable
Recruiting
Conditions
Dorsalgia
M54
F45.41
Registration Number
DRKS00020416
Lead Sponsor
Bereichs Schmerzmedizin und SchmerzpsychologieUniversitätsklinikum Hamburg-Eppendorf (UKE)?Zentrum für Anästhesiologie und Intensivmedizin?Klinik und Poliklinik für Anästhesiologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
69
Inclusion Criteria

chronic low back pain

Exclusion Criteria

Other chronic pain predominant
non sufficient knowledge of language
cannot consent
major depressive disorder
diagnosed fibromyalgia
back pain induced by tumor
cognitive impairment
health status prohibits participation
Galactosemia
Lack of lactase
glucose-Galactose-malabsorbtion
chronic diseases with a dominant role on disability (e.g., rheumatic disorders, cancer, severe heart diseases)
pain-relevant red flags” (Koes et al., 2010)
inflammatory or neuropathic back pain
severe acute or chronic mental disorders (such as psychosis)
pregnancy and breastfeeding
Koes BW, van Tulder M, Lin CW, Macedo LG, Mc Auley J, Maher C (2010) An updated overview of clinical guidelines for the management of non- specific low back pain in primary care. Eur Spine J 19(12):2075–94.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
average pain on a numeric rating scale between 0 = no pain to 10 = strongest pain imaginable). Points of data collection: before the intervention, shortly after the intervention, 3 month after the intervention
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath